Jyothy Labs Capital Structure Change

Jyothy Labs Earnings Call Transcript: Key Takeaways

Q2 EBITDA margin collapsed to 2.5% (16.1% last year) on a 34.8% gross margin. Management gave no numeric guidance and made H2 recovery conditional on commodity stability.

Jyothy Labs Results Update

Jyothy Labs posted Q2 FY27 revenue of ₹760 crore and PAT of ₹10.6 crore. H1 FY27 revenue reached ₹1,533 crore with PAT of ₹58.2 crore amid margin pressure.

Jyothy Labs Investor Presentation: Key Takeaways

Q2 FY27 revenue rose 3.3% to ₹760 Cr, but operating EBITDA margin fell to 2.5% and PAT dropped 87.9% to ₹10.6 Cr on raw-material and packaging inflation.

Jyothy Labs Q2 FY27 Results: Net Profit ₹10.6 Cr, Down 87.9% YoY

Jyothy Labs Ltd reported revenue from operations of ₹760 Cr (+3.2% YoY) and net profit of ₹10.6 Cr (-87.9% YoY) for Q2 FY27.

Key figure

Net profit ₹10.6 Cr · -87.9% YoY

Jyothy Labs Board Meeting Date

Jyothy Labs intimated that its board meets on November 4, 2026 to consider a proposal for buyback of fully paid-up equity shares. Trading window stays closed until 48 hours after the outcome is disclosed.

Jyothy Labs Promoter Buying (Off-Market)

Jyothy Labs filed its quarterly shareholding pattern. It disclosed an inter-se gift of shares within the promoter group, adding family trusts to the promoter group category.

Evonile Pharma Capital Structure Change

Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.

Value

₹884.8 Cr

Execution

Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026

Share India Securities Capital Structure Change

Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.

Arvaya Healthcare Capital Structure Change

Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.

Value

₹210.0 Cr

Mittal Life Style Capital Structure Change

Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.

Zodiac JRD MKJ Capital Structure Change

Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.

Value

₹40.00 Cr

Baba Arts Capital Structure Change

Skybridge Interactive LLP, a non-promoter acquirer, disclosed under Reg 29(2) that it acquired 65,00,000 shares of Baba Arts, raising its stake from 62.28% to 74.67%. The acquisition was off-market under a share purchase agreement dated 25 February 2026.